Published in Klin Monbl Augenheilkd on September 12, 2012
Ranibizumab in choroidal neovascularisation associated with ocular sarcoidosis. BMJ Case Rep (2013) 0.75
Course of disease in multifocal choroiditis lacking sufficient immunosuppression: a case report. J Med Case Rep (2016) 0.75
Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea. Sci Rep (2017) 0.75
EULAR recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 3.37
VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci (2001) 3.08
Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol (2003) 2.20
Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Rheumatol Int (2011) 1.64
Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am J Pathol (2001) 1.53
[Early clinical results with mycophenolate mofetil in immunosuppressive therapy of ocular pemphigoid]. Klin Monbl Augenheilkd (2001) 1.40
Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest Ophthalmol Vis Sci (2001) 1.36
Ophthalmomyiasis externa due to the sheep botfly Oestrus ovis (Diptera: Oestridae) in southwest Germany. Ger J Ophthalmol (1995) 1.33
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 1.32
Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor. Graefes Arch Clin Exp Ophthalmol (1998) 1.15
Helicobacter pylori infection in anterior uveitis. Infection (2005) 1.11
Cryopreserved human amniotic membrane for ocular surface reconstruction. Graefes Arch Clin Exp Ophthalmol (2000) 1.05
Interferon as a treatment for uveitis associated with multiple sclerosis. Br J Ophthalmol (2005) 1.05
Successful treatment of acute visual loss in Muckle-Wells syndrome with interleukin 1 receptor antagonist. Ann Rheum Dis (2005) 1.05
[Epidemiology of uveitis in juvenile idiopathic arthritis from a national paediatric rheumatologic and ophthalmologic database]. Klin Monbl Augenheilkd (2005) 1.04
Tumour necrosis factor alpha and interleukin 6 gene expression in keratocytes from patients with rheumatoid corneal ulcerations. Br J Ophthalmol (2003) 1.03
Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice. J Natl Cancer Inst (2001) 1.00
Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis. Br J Ophthalmol (2009) 1.00
[Severe eye involvement in pemphigus vulgaris]. Ophthalmologe (1995) 0.98
Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study. Br J Ophthalmol (1998) 0.97
Mediation of calcium-independent contraction in trabecular meshwork through protein kinase C and rho-A. Invest Ophthalmol Vis Sci (2000) 0.96
[Uveitis in conjunction with rheumatological diseases in childhood]. Ophthalmologe (2005) 0.96
Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye. Ophthalmology (1993) 0.94
Effects of local and systemic viral interleukin-10 gene transfer on corneal allograft survival. Gene Ther (2006) 0.92
CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury. Am J Pathol (2000) 0.92
Adenovirus-mediated gene transfer of interleukin-4 to corneal endothelial cells and organ cultured corneas leads to high IL-4 expression. Exp Eye Res (1999) 0.91
[Interferon alpha-associated retinopathy in patients with chronic hepatitis C]. Klin Monbl Augenheilkd (2005) 0.91
[Current practice of immune prophylaxis and therapy in perforating keratoplasty. A survey of members of the Cornea Section of the German Ophthalmological Society]. Ophthalmologe (2003) 0.90
Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease. Rheumatology (Oxford) (2004) 0.90
[Anti-TNF-α treatment for uveitis. Analysis of the current situation]. Ophthalmologe (2011) 0.90
[Therapy and prognosis of bacterial keratitis]. Ophthalmologe (2007) 0.90
Corneal endothelial toxicity of different lidocaine concentrations. J Cataract Refract Surg (2000) 0.89
Behçet's disease: epidemiology and eye manifestations in German and Mediterranian patients. Ger J Ophthalmol (1995) 0.88
Retinal toxicity of liposome-incorporated and free ofloxacin after intravitreal injection in rabbit eyes. Int Ophthalmol (1999) 0.88
PVR as a complication of rhegmatogeneous retinal detachment: a solved problem? Br J Ophthalmol (2006) 0.88
MMF and eye disease. Lupus (2005) 0.87
[Drug-induced exudative erythema multiforme major with a chronic progressive course and bilateral blindness. Clinical and immunohistologic follow-up]. Klin Monbl Augenheilkd (1990) 0.86
[Pigmented retinopathy as a presenting sign of mitochondrial encephalomyopathy without external ophthalmoplegia]. Ophthalmologe (2003) 0.86
Autologous translocation of the choroid and RPE in age-related macular degeneration: 1-year follow-up in 30 patients and recommendations for patient selection. Eye (Lond) (2007) 0.86
Topical liposome-encapsulated FK506 for the treatment of endotoxin-induced uveitis. Ocul Immunol Inflamm (1998) 0.86
[Cyclosporine monitoring in patients with chronic uveitis]. Ophthalmologe (2005) 0.86
[Acute retinal necrosis syndrome: analysis, therapy and long-term follow up of 14 eyes]. Klin Monbl Augenheilkd (2000) 0.85
HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet's disease and complete remission of both disorders with interferon alpha. Ann Rheum Dis (2001) 0.85
Retinal pigment epithelium (RPE)-choroid graft translocation in the treatment of an RPE tear: preliminary results. Br J Ophthalmol (2008) 0.85
Comparative analysis of the association of HLA-B*51 suballeles with Behçet's disease in patients of German and Turkish origin. Tissue Antigens (2001) 0.84
In vivo fluorescence microscopy of corneal neovascularization. Graefes Arch Clin Exp Ophthalmol (1998) 0.83
Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature. Clin Exp Rheumatol (2005) 0.83
Device drug delivery to the eye. Collagen shields, iontophoresis, and pumps. Ophthalmology (1991) 0.83
[Meibomian glands : part III. Dysfunction - argument for a discrete disease entity and as an important cause of dry eye]. Ophthalmologe (2009) 0.83
[Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis]. Ophthalmologe (2001) 0.83
[Transcorneal-paracorneal penetration route for topical application of drugs to the eyt. Mycophenolate mofetil as a model substance]. Ophthalmologe (2003) 0.82
Detection of tumor necrosis factor alpha and interleukin 1 alpha gene expression in human lens epithelial cells. J Cataract Refract Surg (2000) 0.82
[Corneal wound healing. II. Treatment of disorders of wound healing]. Ophthalmologe (2003) 0.82
Prevalence of Adamantiades-Behçet's disease in Germany and the municipality of Berlin: results of a nationwide survey. Clin Exp Rheumatol (2006) 0.82
[Influence of donor lamella thickness on visual acuity after Descemet's stripping automated endothelial keratoplasty (DSAEK)]. Ophthalmologe (2014) 0.82
[Cogan I syndrome: clinical aspects, therapy and prognosis]. Ophthalmologe (2000) 0.81
[Diseases of the outer eye in rheumatoid arthritis]. Z Rheumatol (2010) 0.81
Intraocular antibody production in intraocular inflammation. Graefes Arch Clin Exp Ophthalmol (2000) 0.81
Therapy of Behçet's disease. Ger J Ophthalmol (1996) 0.81
Immunohistological findings in a patient with unusual late onset manifestations of ligneous conjunctivitis. Br J Ophthalmol (1999) 0.81
Influence of cyclodextrins on the in vitro corneal permeability and in vivo ocular distribution of thalidomide. J Ocul Pharmacol Ther (1999) 0.81
[Keratoplasty à chaud]. Ophthalmologe (1995) 0.81
[Intravitreal implants: drug carriers and carriers of hope?]. Ophthalmologe (2011) 0.80
[Secondary glaucoma in childhood uveitis]. Ophthalmologe (2008) 0.80
Is ex vivo adenovirus mediated gene transfer a therapeutic option for the treatment of corneal diseases? Br J Ophthalmol (2005) 0.80
Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice. Urology (2000) 0.80
In vivo study of leukocyte-endothelium interaction in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci (1995) 0.80
Optical coherence tomography on autologous translocation of choroid and retinal pigment epithelium in age-related macular degeneration. Eye (Lond) (2007) 0.80
[Keratomalacia in rheumatoid arthritis: immunohistologic and enzyme histochemical studies]. Z Rheumatol (1991) 0.80
[Pseudophakia in children with juvenile arthritis]. Ophthalmologe (1998) 0.80
[Diagnostics and treatment of primary vitreoretinal lymphoma]. Ophthalmologe (2015) 0.80
[Comments on the pathogenesis of Behçet's disease. A key to understanding new therapies?]. Ophthalmologe (2012) 0.80
Ocular involvement is associated with HLA-B51 in Adamantiades-Behçet's disease. Eye (Lond) (2008) 0.80
Neuroendocrine alterations in uveitis patients. Graefes Arch Clin Exp Ophthalmol (1994) 0.79
Topical treatment of severe corneal ulcers with cyclosporin A. Graefes Arch Clin Exp Ophthalmol (1989) 0.79
[Ocular toxocariasis. Diagnostic and therapeutic options]. Ophthalmologe (2003) 0.79
[Confocal microscopy in corneal dystrophies: a comparison between confocal slit scanning (ConfoScan P2) and laser scanning microscopy (Rostock Cornea Modul-HRT II)]. Klin Monbl Augenheilkd (2006) 0.79
[How "safe" is corneal transplantation? A contribution on the risk of HSV-transmission due to corneal transplantation]. Klin Monbl Augenheilkd (2005) 0.79
Long-term (4 years) results of choroidal hemangioma treated with proton beam irradiation. Graefes Arch Clin Exp Ophthalmol (2014) 0.79
[Behçet's disease - ophthalmological and general aspects part I : etiology, pathogenesis and diagnostics]. Ophthalmologe (2012) 0.79
[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 1 Introduction/preliminary comments]. Z Rheumatol (2014) 0.79
Traumatic wound dehiscence after penetrating keratoplasty. Acta Ophthalmol Scand (1996) 0.79
[Noise field findings in 24 patients with coronary heart disease]. Klin Monbl Augenheilkd (2000) 0.79
Shifting of the proliferative vitreoretinopathy milieu after tamponade with heavy silicone oil in eyes prone to proliferative vitreoretinopathy and bleeding. Br J Ophthalmol (2009) 0.78
[Ocular toxocariasis. From biology to therapy]. Ophthalmologe (2007) 0.78
[Lymphoma of the ocular adnexa]. Ophthalmologe (2015) 0.78
Compound-heterozygous mutations in the plasminogen gene predispose to the development of ligneous conjunctivitis. Blood (1999) 0.78
Matrix metalloproteinases in sterile corneal melts. Ann N Y Acad Sci (1999) 0.78
Experimental intravitreal application of ciprofloxacin in rabbits. Ophthalmologica (1999) 0.78
Thalidomide inhibits leukocyte-endothelium interaction in endotoxin-induced uveitis. Ophthalmic Res (2001) 0.78
[Diagnosis and treatment of ocular toxoplasmosis : a survey of German-speaking ophthalmologists]. Ophthalmologe (2008) 0.78
[The molecular mechanisms of neovascular age-related macular degeneration]. Ophthalmologe (2003) 0.78
[Typical and atypical ocular manifestations of Behçet's disease]. Ophthalmologe (2012) 0.78
[Behcet's disease--ophthalmological and general aspects: Part 2: Therapy]. Ophthalmologe (2013) 0.78
Successful infliximab treatment of posterior scleritis in a 13-year-old child refractory to other immunosuppressive therapy. Graefes Arch Clin Exp Ophthalmol (2007) 0.78
The Ets-1 transcription factor is involved in pterygial angiogenesis. Anat Histol Embryol (2007) 0.78
[In vitro bovine and human lens epithelial cell culture studies on inhibition of posterior capsule opacification using a cyclic RGD peptide]. Ophthalmologe (2001) 0.78
[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 3 Clinical symptoms]. Z Rheumatol (2014) 0.77
The role of endogenous growth factors to support corneal endothelial migration after wounding in vitro. Exp Eye Res (2000) 0.77